Physical Exercise in Immunotherapy
Sports medicine - open · 2026
Biologically plausible case for exercise boosting checkpoint inhibitor efficacy, but it's all mice and cell culture so far, not patients.
Studiet
Narrative review, preclinical and mechanistic literature on physical exercise as an adjunct to cancer immunotherapy, no primary human clinical trial data reported.
Hvad de fandt
No new quantitative findings; the review reports that in preclinical models exercise enhances anti-tumor immune responses and sensitizes tumors to checkpoint inhibitors, improving tumor control, but gives no effect sizes, doses, or human outcome data, and states plainly that clinical evidence remains limited.
Studiedesign
This is a narrative literature review of preclinical (mostly animal) and mechanistic studies on exercise, the tumor microenvironment, and PD-1/PD-L1 checkpoint blockade efficacy. It sits at the bottom of the evidence hierarchy, below cohort studies and RCTs, and is explicitly hypothesis-generating rather than practice-defining.
Metode
No search strategy, PRISMA flow, or quality/risk-of-bias grading is described in the abstract, so this reads as a narrative synthesis rather than a systematic review, which leaves it open to selective citation and publication bias favouring positive preclinical results. Nearly all mechanistic claims (cytokine signalling, metabolic reprogramming, chemokine gradients) come from animal or in vitro models, which frequently fail to translate to human oncology outcomes, and the abstract itself concedes clinical evidence is limited. A clinician cannot verify any dose-response threshold from this abstract because none is given; that would require reading the primary trials cited within the full review.
Vurderingen
Because there is no clinical effect size, confidence interval, or p-value to weigh, there is nothing here to judge as statistically or clinically significant yet; this is mechanistic rationale-building, not evidence of a causal benefit in humans. The design cannot support any claim that exercise improves checkpoint inhibitor outcomes in patients, only that it is biologically plausible enough to justify trials. It is also a narrative, not systematic, review, so there is no stated search strategy or quality appraisal of the preclinical studies it draws on, meaning selective citation of favourable findings cannot be ruled out.
Begrænsningen
There are no cited human RCTs testing whether structured exercise improves response rates, progression-free survival, or overall survival in patients on checkpoint inhibitors, which is the data needed before this changes anything in the clinic.
Referencestudie
This builds on the broader exercise-oncology literature established by groups like Pedersen and colleagues showing exercise-induced NK cell mobilization reduces tumor growth in mouse models, extending that mechanistic thread specifically into the PD-1/PD-L1 checkpoint inhibitor era rather than overturning any prior clinical landmark.
Hvad du gør på mandag
This does not change Monday practice; it is a rationale for future trials, not a basis for prescribing exercise as an immunotherapy adjunct with any specific dose or timing claim.
In practice
This applies to physios running exercise-oncology programmes for patients on checkpoint inhibitors, not to the general MSK caseload. Monday practice doesn't change: keep prescribing exercise per existing exercise-oncology guidelines (individualised aerobic plus resistance work dosed to fatigue and treatment tolerance) for the fitness, fatigue and quality-of-life gains we already have good human evidence for, rather than telling patients it will make their drug work better. On the S&C floor this is niche, relevant only if you're coaching a cancer survivor or someone still on treatment, and the same rule holds: train for capacity and tolerance, don't reframe programming around an unproven immunotherapy-boosting claim. The caveat worth passing on to colleagues and patients is that 'exercise helps immunotherapy work' is currently a mouse-model hypothesis, not a clinical fact, so it shouldn't influence decisions about exercise timing or intensity around treatment cycles.
De fem studier, der betyder noget — hver uge, gratis.
Vi læser hele litteraturen om sportsmedicin, genoptræning og præstation og vurderer de studier, der er din tid værd.
Få den gratis ugentlige udgaveRelaterede vurderinger
Læs på dit sprog: English · Français · Deutsch · Español · Italiano · Nederlands · Dansk · Svenska